A STUDY TO EVALUATE PARITAPREVIR WITH RITONAVIR (ABT-450/R) WHEN GIVEN TOGETHER WITH OMBITASVIR AND WITH AND WITHOUT RIBAVIRIN (RBV) IN TREATMENT-NAÏVE PARTICIPANTS WITH GENOTYPE 1, 2 OR 3 CHRONIC HEPATITIS C VIRUS (HCV):